Health Catalyst’s (HCAT) “Neutral” Rating Reiterated at Cantor Fitzgerald

Cantor Fitzgerald reissued their neutral rating on shares of Health Catalyst (NASDAQ:HCAT) in a research report sent to investors on Monday,Benzinga reports.

A number of other research analysts have also recently weighed in on the stock. Citigroup dropped their price objective on shares of Health Catalyst from $2.75 to $1.75 and set a “neutral” rating for the company in a research note on Friday, March 13th. Stifel Nicolaus dropped their price objective on shares of Health Catalyst from $3.75 to $2.00 and set a “hold” rating for the company in a research note on Friday, March 13th. Weiss Ratings reissued a “sell (e+)” rating on shares of Health Catalyst in a research note on Friday, March 27th. Raymond James Financial set a $3.00 price objective on shares of Health Catalyst in a research note on Friday, March 13th. Finally, Canaccord Genuity Group dropped their price objective on shares of Health Catalyst from $5.00 to $2.00 and set a “buy” rating for the company in a research note on Friday, March 13th. Four research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $2.77.

Health Catalyst Trading Down 9.5%

Shares of Health Catalyst stock opened at $1.34 on Monday. Health Catalyst has a 12-month low of $0.96 and a 12-month high of $4.33. The company has a current ratio of 1.69, a quick ratio of 1.89 and a debt-to-equity ratio of 1.10. The stock has a market cap of $99.01 million, a PE ratio of -0.36 and a beta of 1.63. The company has a 50-day moving average of $1.35 and a two-hundred day moving average of $2.03.

Health Catalyst (NASDAQ:HCAT) last issued its quarterly earnings data on Monday, May 11th. The company reported $0.02 earnings per share for the quarter, topping analysts’ consensus estimates of $0.01 by $0.01. Health Catalyst had a negative net margin of 87.69% and a negative return on equity of 3.52%. The business had revenue of $70.76 million during the quarter, compared to analysts’ expectations of $69.24 million. On average, research analysts anticipate that Health Catalyst will post -0.28 EPS for the current fiscal year.

Hedge Funds Weigh In On Health Catalyst

Hedge funds have recently made changes to their positions in the stock. First Light Asset Management LLC lifted its holdings in shares of Health Catalyst by 9.9% during the 3rd quarter. First Light Asset Management LLC now owns 13,436,220 shares of the company’s stock valued at $38,293,000 after acquiring an additional 1,206,039 shares in the last quarter. Vanguard Group Inc. lifted its holdings in shares of Health Catalyst by 2.9% during the 3rd quarter. Vanguard Group Inc. now owns 4,295,691 shares of the company’s stock valued at $12,243,000 after acquiring an additional 119,117 shares in the last quarter. Whetstone Capital Advisors LLC lifted its holdings in shares of Health Catalyst by 0.5% during the 4th quarter. Whetstone Capital Advisors LLC now owns 3,750,377 shares of the company’s stock valued at $8,963,000 after acquiring an additional 19,027 shares in the last quarter. Nepsis Inc. lifted its holdings in shares of Health Catalyst by 26.6% during the 4th quarter. Nepsis Inc. now owns 1,915,794 shares of the company’s stock valued at $4,579,000 after acquiring an additional 402,762 shares in the last quarter. Finally, Geode Capital Management LLC lifted its holdings in shares of Health Catalyst by 11.4% during the 2nd quarter. Geode Capital Management LLC now owns 1,662,455 shares of the company’s stock valued at $6,269,000 after acquiring an additional 169,580 shares in the last quarter. Institutional investors and hedge funds own 85.00% of the company’s stock.

About Health Catalyst

Health Catalyst (NASDAQ: HCAT) is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information.

The core of Health Catalyst’s offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment.